Selectis Health, Inc. — Earnings
Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2025-12-31 | $10M | ↓-7.0% | — | — | — |
| 2025-09-30 | $11M | ↑+8.2% | $752K | ↑+146.8% | -2.7% |
| 2025-06-30 | $10M | ↑+8.9% | $-308K | ↓-138.8% | -4.3% |
| 2025-03-31 | $10M | ↑+10.5% | $-656K | ↑+36.6% | -4.0% |
| 2024-12-31 | $10M | ↑+13.0% | — | — | — |
| 2024-09-30 | $10M | ↑+10.7% | $-2M | ↑+29.0% | -11.7% |
| 2024-06-30 | $10M | ↑+7.3% | $794K | ↑+137.8% | -8.0% |
| 2024-03-31 | $9M | ↓-1.2% | $-1M | ↓-125.7% | -7.3% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2025 (Q4)
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Go deeper
GBCS Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeyGBCS Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics